From the case: Glioblastoma NOS (bevacizumab pseudoresponse)
MRI Brain (after bevacizumab)
Coronal T1 C+
- “ This case illustrates a common follow-up for glioblastoma in which an antiangiogenic chemotherapy (bevacizumab) was introduced after tumor recurre...”
Updating… Please wait.
Unable to process the form. Check for errors and try again.
Thank you for updating your details.